Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
NeuroMetrix Inc
NUROCurrent price
4.60 USD
+0.085 USD (+1.88%)
Last closed
4.51 USD
Company
www.neurometrix.com
ISIN
US6412558073
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
7 966 491 USD
Yield for 12 month
+12.62 %
1Y
3Y
5Y
10Y
15Y
NURO
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts. Address: 4B Gill Street, Woburn, MA, United States, 01801
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
50.00 USDP/E ratio
–Dividend Yield
–Current Year
+5 901 425 USD
Last Year
+8 256 073 USD
Current Quarter
+587 314 USD
Last Quarter
+769 148 USD
Current Year
+3 947 413 USD
Last Year
+5 750 240 USD
Current Quarter
+311 957 USD
Last Quarter
+491 919 USD
Key Figures NURO
1 year
3 years
5 years
10 years
EBITDA
-8 582 317 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-28.21 %
PEG Ratio
-0.010
Return On Equity TTM
-42.78 %
Wall Street Target Price
50.00 USD
Revenue TTM
3 767 764 USD
Book Value
7.99 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-51.20 %
Dividend Yield
–
Gross Profit TTM
5 750 240 USD
Earnings per share
-4.51 USD
Diluted Eps TTM
-4.51 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-203.71 %
Dividend Analytics NURO
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History NURO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
28.03.2007
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
0
Consistent Years
0
Continuous Dividends
1
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:8
Payout Ratio
–
Last Split Date
22.11.2023
Stock Valuation NURO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.25
Price Sales TTM
2.11
Enterprise Value EBITDA
1.46
Price Book MRQ
0.49
Financials NURO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NURO
For 52 weeks
2.66 USD
4.73 USD
50 Day MA
4.08 USD
Shares Short Prior Month
42 403
200 Day MA
3.91 USD
Short Ratio
1.52
Shares Short
31 065
Short Percent
1.54 %
BeatStart